Chimeric proteins comprising borrelia polypeptides and uses therefor
US6248562A · kind A · utility
63Cited by
4References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 29, 1994 |
| Grant date | Jun 19, 2001 |
| Priority date | — |
| Expiry date | Apr 29, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Chimeric nucleic acids encoding chimeric Borrelia proteins consisting of at least two antigenic polypeptides from corresponding and/or non-corresponding proteins from the same and/or different species of Borrelia, are disclosed. Chimeric proteins encoded by the nucleic acid sequences are also disclosed. The chimeric proteins are useful as vaccine immunogens against Lyme borreliosis, as well as for immunodiagnostic reagents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.